2seventy bio Inc (TSVT)
4.51
+0.11
(+2.50%)
USD |
NASDAQ |
May 24, 16:00
4.61
+0.10
(+2.22%)
After-Hours: 20:00
2seventy bio Total Liabilities (Quarterly): 303.61M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 303.61M |
| December 31, 2023 | 310.13M |
| September 30, 2023 | 334.38M |
| June 30, 2023 | 338.22M |
| March 31, 2023 | 341.11M |
| December 31, 2022 | 346.20M |
| September 30, 2022 | 385.56M |
| Date | Value |
|---|---|
| June 30, 2022 | 408.42M |
| March 31, 2022 | 404.50M |
| December 31, 2021 | 399.85M |
| September 30, 2021 | 251.37M |
| June 30, 2021 | 255.06M |
| December 31, 2020 | 237.99M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
237.99M
Minimum
Dec 2020
408.42M
Maximum
Jun 2022
332.03M
Average
338.22M
Median
Jun 2023
Total Liabilities (Quarterly) Benchmarks
| Bristol-Myers Squibb Co | 82.48B |
| Johnson & Johnson | 101.95B |
| Macrogenics Inc | 142.13M |
| Akebia Therapeutics Inc | 252.74M |
| Tango Therapeutics Inc | 141.77M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 511.05M |
| Shareholders Equity (Quarterly) | 207.44M |
| Current Ratio | 3.524 |